BYFC vs JAZZ · rev $184.0K vs P/E 1988, rev $2.28B
Broadway Financial Corporation (BYFC) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Broadway Financial Corporation (BYFC) is a banks - regional company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported BYFC revenue for 2025-12-31 was $184.0K. Net income was -$24.8M. Revenue was up 18.7% from 2024-12-31 to 2025-12-31. BYFC currently screens at market cap $69.4M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
BYFC currently screens at market cap $69.4M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the BYFC and JAZZ stock pages for the full models.
Not investment advice.